ICU Medical Stock (NASDAQ:ICUI)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$139.83

52W Range

$107.00 - $160.29

50D Avg

$127.40

200D Avg

$134.53

Market Cap

$3.57B

Avg Vol (3M)

$288.73K

Beta

0.78

Div Yield

-

ICUI Company Profile


ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system transfer devices (ChemoClave, ChemoLock) and the Diana compounding system for safe preparation. They also provide a comprehensive range of intravenous (IV) solutions, diluents, and irrigation fluids, available in diverse packaging options like flexible containers and pour bottles. These include common formulations such as sodium chloride, dextrose, balanced electrolytes, lactated ringer's, mannitol, and sterile water, alongside specialized irrigation solutions like acetic acid and glycine. In medication management, ICU Medical offers sophisticated infusion pumps, including the Plum 360 and LifeCare PCA brands. Its advanced ICU Medical MedNet software enhances medication safety by integrating smart pumps with hospital electronic health records (EHRs), asset tracking, and alarm notification platforms. Accompanying professional services are also provided. For critical care environments, their portfolio features: Hemodynamic Monitoring: Systems like Cogent 2-in-1 and CardioFlo. Cardiac Output & Oximetry: TDQ, OptiQ, and TriOx catheters. Blood Pressure Transducers: Such as Transpac. Blood Sampling Systems: Including the SafeSet closed blood sampling and conservation systems. The company distributes its products to a wide spectrum of healthcare providers, including acute care hospitals, wholesalers, ambulatory clinics, and various alternate site facilities such as outpatient clinics, home healthcare services, and long-term care centers. Established in 1984, ICU Medical maintains its headquarters in San Clemente, California.

Show More

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

15,000

IPO Date

Mar 31, 1992

Website

ICUI Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Other deferred revenue$1.18M$503.00K$1.92M
Software revenue$31.37M$29.91M$19.95M
Government Grant Revenue$-2.07M$7.34M$944.00K
Equipment revenue$74.84M$55.93M$35.87M
Infusion Consumables-$1.04B-
Vital Care-$690.77M-
Infusion Systems-$652.41M-

Fiscal year ends in Dec 25 | Currency in USD

ICUI Financial Summary


Dec 25Dec 24Dec 23
Revenue$2.23B$2.38B$2.26B
Operating Income$42.83M$42.96M$22.82M
Net Income$6.79M$-117.69M$-29.66M
EBITDA$42.83M$42.96M$253.20M
Basic EPS$0.03$-4.83$-1.23
Diluted EPS$0.03$-4.83$-1.23

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26May 07, 26 | 12:00 AM
Q4 25Feb 20, 26 | 4:30 PM
Q3 25Nov 06, 25 | 4:30 PM

Peer Comparison


TickerCompany
IRONDisc Medicine, Inc.
HTFLHeartflow, Inc. Common Stock
PBHPrestige Consumer Healthcare Inc.
PRGOPerrigo Company plc
TARSTarsus Pharmaceuticals, Inc.
TVTXTravere Therapeutics, Inc.
HAEHaemonetics Corporation
LIVNLivaNova PLC
XRAYDENTSPLY SIRONA Inc.
ARQTArcutis Biotherapeutics, Inc.